Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mentor Corp.

Division of Johnson & Johnson

Latest From Mentor Corp.

FDA Disputes Study On Breast Implant Safety

US FDA has taken the rare step of publicly disputing a study that seemed to show elevated risks of long-term adverse events associated with silicone breast implants.

Safety Medical Device

Cases Of Rare Lymphoma Linked To Breast Implants Increase

US FDA is now aware of 414 cases of breast implant-associated anaplastic large cell lymphoma. The agency says that updated medical literature estimates of the lifetime risk of textured breast implanted patients developing BIA-ALCL range between 1 in 3,817 to 1 in 30,000.

Regulation Safety

Deals Shaping The Medical Industry, July 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2016.

BioPharmaceutical Deals

Women In Pharma: Bayer Executives Challenge Industry Expectations

Three female executives from Bayer Healthcare and Consumer Care discuss making it to the upper echelons of the pharma industry, how to challenge expectations and future predictions for the life sciences world.

Metabolic Disorders Cardiovascular
See All

Company Information